Institute of Biomedical Research of Barcelona
Targeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma.
Targeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma.
-
Associated Personnel
-
Associated Research Groups
-
Associated Departments
Molecular and Cellular Biomedicine
Read moreOur research is devoted to the study of the molecular mechanisms of cell death and proliferation, as they are involved in the development of different human pathologies.
